➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: October 27, 2021

DrugPatentWatch Database Preview

Tenapanor hydrochloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic drug sources for tenapanor hydrochloride and what is the scope of freedom to operate?

Tenapanor hydrochloride is the generic ingredient in one branded drug marketed by Ardelyx Inc and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Tenapanor hydrochloride has thirty-five patent family members in twenty-one countries.

Summary for tenapanor hydrochloride

International Patents:	35
US Patents:	4
Tradenames:	1
Applicants:	1
NDAs:	1
Clinical Trials:	14
What excipients (inactive ingredients) are in tenapanor hydrochloride?	tenapanor hydrochloride excipients list
DailyMed Link:	tenapanor hydrochloride at DailyMed

Recent Clinical Trials for tenapanor hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Ardelyx	Phase 4
Ardelyx	Phase 2/Phase 3
Kyowa Hakko Kirin Co., Ltd	Phase 2

See all tenapanor hydrochloride clinical trials

US Patents and Regulatory Information for tenapanor hydrochloride

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ardelyx Inc	IBSRELA	tenapanor hydrochloride	TABLET;ORAL	211801-001	Sep 12, 2019		DISCN	Yes	No	⤷ Try it Free	⤷ Try it Free	Y	Y		⤷ Try it Free
Ardelyx Inc	IBSRELA	tenapanor hydrochloride	TABLET;ORAL	211801-001	Sep 12, 2019		DISCN	Yes	No	⤷ Try it Free	⤷ Try it Free	Y	Y		⤷ Try it Free
Ardelyx Inc	IBSRELA	tenapanor hydrochloride	TABLET;ORAL	211801-001	Sep 12, 2019		DISCN	Yes	No	⤷ Try it Free	⤷ Try it Free				⤷ Try it Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for tenapanor hydrochloride

Subscribe to access the full database, or Try it Free
Country	Patent Number	Estimated Expiration
South Korea	20170091783	⤷ Try it Free
Lithuania	2384318	⤷ Try it Free
South Korea	20110110287	⤷ Try it Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.